Investor Relations

Biography

Michael Miller image

Michael P. Miller

Board Member
Mr. Miller brings nearly 40 years of strategic leadership and commercial growth experience in the pharmaceutical industry, where he most recently served as Executive Vice President, U.S. Commercial at Jazz Pharmaceuticals. In this role, Mr. Miller led a 450+ person team that generated $2.3 billion in revenues in 2020 and led all commercial operations for drugs including Xyrem® and Sunosi® for neurological disorders and Vxyeos®, Erwinaze®, Defitelio®, and Zepzelca® for difficult to treat cancers. Prior to Jazz, he served in senior executive management positions with commercial, marketing, market access, and sales responsibilities at VIVUS, Genentech (until acquisition by Roche), Connetics Corporation, and ALZA Corporation. He began his pharmaceutical career at Syntex Laboratories in various commercial roles until its acquisition by Roche. Mr. Miller currently sits on the Board of Puma Biotechnology and serves as an advisor to several private and public biotechnology companies. He previously sat on the Board of the Leukemia and Lymphoma Society, Silicon Valley and Monterey Chapter. Mr. Miller holds a B.S. in Finance from the University of San Francisco and an MBA from San Francisco State University.